Gabriella Cotugno

3PUBLICATIONS
28CO-AUTHORS
Predictive and prognostic markersInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Mar 28, 2024
Development of a Potency Assay for Nous-209, a Multivalent Neoantigens-Based Genetic Cancer Vaccine.

Rosa Bartolomeo, Fulvia Troise, Simona Allocca

|Mar 20, 2024
Phase I Trial of Viral Vector-Based Personalized Vaccination Elicits Robust Neoantigen-Specific Antitumor T-Cell Responses.

Anna Morena D'Alise, Guido Leoni, Gabriella Cotugno

|Feb 08, 2024
Tumor Burden Dictates the Neoantigen Features Required to Generate an Effective Cancer Vaccine.

Irene Garzia, Linda Nocchi, Lidia Avalle

Pageof 1